Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum lipids in hepatoma.

E A Alsabti

    Oncology
    |January 1, 1979
    PubMed
    Summary

    Serum lipid levels can help distinguish between hepatoma (liver cancer) and liver cirrhosis. This finding offers a potential tool for the early detection of liver cancer in patients with cirrhosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The immunostatus of untreated cervical carcinoma.

    Gynecologic oncology·1980
    Same author

    Histopathological subtypes of Hodgkin's disease in childhood in Iraq.

    The Japanese journal of experimental medicine·1979
    Same author

    Hodgkin's disease in childhood.

    Journal of cancer research and clinical oncology·1979
    Same author

    Serum proteins in breast cancer.

    The Japanese journal of experimental medicine·1979
    Same author

    Clinical trials in vaccination with leukemia associated antigens in acute myelogenous leukemia.

    The Japanese journal of experimental medicine·1979
    Same author

    Periodic acid-thionin Schiff/potassium hydroxide/periodic acid-Schiff (PAT/KOH/PAS) approach in the detection of adenocarcinoma.

    The Japanese journal of experimental medicine·1979

    Area of Science:

    • Biochemistry
    • Oncology
    • Hepatology

    Background:

    • Liver cirrhosis is a significant risk factor for developing hepatoma.
    • Early detection of hepatoma is crucial for improving patient outcomes.
    • Distinguishing between liver cirrhosis and hepatoma can be challenging.

    Purpose of the Study:

    • To investigate differences in serum lipid profiles between patients with hepatoma, liver cirrhosis, and healthy controls.
    • To evaluate the utility of serum lipid determination in differentiating hepatoma from liver cirrhosis.
    • To explore the potential of serum lipids as an early detection marker for hepatoma in cirrhotic patients.

    Main Methods:

    • Serum samples were collected from patients diagnosed with hepatoma, liver cirrhosis, and from healthy individuals.
    • Levels of serum total cholesterol, esterified cholesterol, triglycerides, and phospholipids were quantified.
    • Statistical analysis was performed to compare lipid levels across the different patient groups.

    Main Results:

    • Patients with hepatoma exhibited significantly higher levels of serum total cholesterol, esterified cholesterol, triglycerides, and phospholipids compared to patients with liver cirrhosis.
    • These differences were observed regardless of whether the hepatoma patients had a prior history of liver cirrhosis.
    • Healthy controls showed distinct lipid profiles compared to both patient groups (data not shown in abstract).

    Conclusions:

    • Serum lipid profiles differ significantly between hepatoma and liver cirrhosis.
    • Determination of serum lipids is a valuable method for differentiating between hepatoma and liver cirrhosis.
    • Serum lipid analysis may serve as a valuable tool for the early detection of hepatoma in patients with underlying liver cirrhosis.

    Related Experiment Videos